Physician profile
Emilio C Tayag
NPI 1356409312
$10,793.79
in general payments reported to CMS, 2019-2025
24 companies · $1,488 in 2025
The $1,488 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,868 · 2020: $322 · 2021: $1,353 · 2022: $643 · 2023: $1,768 · 2024: $1,352 · 2025: $1,488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,558 · Travel and Lodging: $1,906 · Education: $140 · Gift: $3.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,558.41 |
| Travel and Lodging | $1,905.65 |
| Education | $139.52 |
| Gift | $3.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $3,381.18 | 2019-2020 | |
| Spineology INC. | $1,954.25 | 2021-2025 | Optimesh Expandable Interbody Fusion System |
| Medical Device Business Services, INC. | $1,210.52 | 2023 | Cerepak Uniform, Trufill, Pulsar Vascular Pulserider Aneurysm Neck Reconstruction Device |
| Medtronic, INC. | $783.44 | 2021-2025 | Midas Rex, Mazor X System, Reacttm |
| Boston Scientific Corporation | $594.52 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Astrazeneca Pharmaceuticals Lp | $522.55 | 2023-2024 | Andexxa |
| Penumbra, INC. | $490.34 | 2019-2025 | Red 72, Penumbra Coil 400, Benchmark |
| Stryker Corporation | $304.16 | 2019-2022 | |
| Integra Lifesciences Corporation | $239.11 | 2021-2025 | Codman Certas, Duraseal Exact Spinal Sealant System, Codman Hakim |
| Medtronic USA, INC. | $215.38 | 2019-2020 | |
| Depuy Synthes Sales INC. | $141.47 | 2021 | |
| Grifols USA, LLC | $135.67 | 2019 | |
| Allergan, INC. | $125.00 | 2019 | |
| Si-Bone, INC. | $121.92 | 2020-2024 | |
| Omniscient Neurotechnology America Ltd | $121.00 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $120.52 | 2025 | Proclaim |
| Biogen, INC. | $104.16 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $100.00 | 2025 | |
| Mallinckrodt Enterprises LLC | $33.76 | 2019 | |
| Integrity Implants INC. | $23.33 | 2022 | |
| Janssen Biotech, INC. | $20.47 | 2024 | Balversa, Akeega, Erleada |
| Celgene Corporation | $18.90 | 2019 | |
| Baxter Healthcare | $17.57 | 2023 | Floseal |
| Cordis US Corp. | $14.57 | 2025 | Mynx Control |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emilio Tayag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.